Chlorothiazide-sodium-structure (Chlorothiazide Na St)
Chlorothiazide Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 47335-330
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlorothiazide Sodium (NDC 47335-330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chlorothiazide-carton (Chlorothiazide Carton)
This text describes Chlorothiazide Sodium, a sterile lyophilized powder used for the preparation of intravenous solutions. The active ingredient is 500mg of Chlorothiazide USP, and the usual adult dosage is 500mg once daily. It is to be reconstituted with a minimum of 18mL of sterile water for injection. This product comes in single-dose vials and should be used immediately after preparation. The reconstituted solution is clear and essentially free from visible particles. The text also includes important information about proper storage and disposal.*
Chlorothiazide-structure (Chlorothiazide Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
